Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 May 11;26(10):4607.
doi: 10.3390/ijms26104607.

Leptin and PAI-1 Levels Are Decreased After a Dietary Intervention in Patients with Irritable Bowel Syndrome

Affiliations
Randomized Controlled Trial

Leptin and PAI-1 Levels Are Decreased After a Dietary Intervention in Patients with Irritable Bowel Syndrome

Andreas-Balázs Szekely et al. Int J Mol Sci. .

Abstract

A diet low in fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) is an established treatment for irritable bowel syndrome (IBS). The starch- and sucrose-reduced diet (SSRD) is a newer, promising diet. Nutrients influence the production of gut hormones, which affect gastrointestinal motility. This study aimed to investigate the changes in copeptin, leptin, PAI-1, C-peptide, and insulin in patients with IBS following a 4-week dietary intervention and to explore whether these hormonal levels correlated with symptom improvements. A total of 142 participants with IBS were randomized to either a 4-week intervention with the SSRD (n = 70) or a low-FODMAP diet (n = 72). Participants completed the study questionnaire, food diary, ROME IV questionnaire, irritable bowel syndrome severity scoring system (IBS-SSS), and visual analog scale for irritable bowel syndrome (VAS-IBS) at baseline and after 4 weeks and 6 months; blood samples were collected at each of these time points. Leptin levels decreased from baseline to 4 weeks in the SSRD group (p = 0.002) but not in the low-FODMAP group (p = 0.153). In the overall study population, leptin (p = 0.001) and PAI-1 (p = 0.019) levels decreased from baseline to 4 weeks. Leptin changes were mainly associated with alterations in carbohydrate intake but not with symptom changes. These findings suggest that the SSRD reduces the levels of leptin in patients with IBS, while PAI-1 levels decrease independently of the dietary intervention, without a corresponding impact on symptoms.

Keywords: C-peptide; IBS; PAI-1; SSRD; copeptin; insulin; leptin; low FODMAP.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest.

Figures

Figure 1
Figure 1
Leptin concentrations at baseline and 4 weeks, stratified by group. SSRD = starch- and sucrose-reduced diet. Low FODMAP = low content of fermentable oligo-, di-, and monosaccharides and polyols. Boxplot of leptin concentrations at baseline and 4 weeks. Wilcoxon signed ranks. p < 0.05 was considered statistically significant.
Figure 2
Figure 2
Flow chart. Study inclusion and exclusion criteria. SSRD = starch- and sucrose-reduced diet. Low FODMAP = low content of fermentable oligo-, di-, and monosaccharides and polyols. IBS-SSS = irritable bowel syndrome severity scoring system [36]. VAS-IBS = Visual Analog Scale for IBS [35]. LCHF = low-carbohydrate high-fat. SCOFF = Sick, Control, One, Fat, Food [54].

Similar articles

References

    1. Lacy B.E., Mearin F., Chang L., Chey W.D., Lembo A.J., Simren M., Spiller R. Bowel disorders. Gastroenterology. 2016;150:1393–1407. doi: 10.1053/j.gastro.2016.02.031. - DOI - PubMed
    1. Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J., Whitehead W.E., Dumitrascu D.L., Fang X., Fukudo S., et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160:99–114. doi: 10.1053/j.gastro.2020.04.014. - DOI - PubMed
    1. Bellini M., Gambaccini D., Stasi C., Urbano M.T., Marchi S., Usai-Satta P. Irritable bowel syndrome: A disease still searching for pathogenesis, diagnosis and therapy. World J. Gastroenterol. 2014;20:8807–8820. - PMC - PubMed
    1. Ng J.J.J., Loo W.M., Siah K.T.H. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review. World J. Hepatol. 2023;15:925–938. doi: 10.4254/wjh.v15.i7.925. - DOI - PMC - PubMed
    1. Roth B., Ohlsson B. Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome—A cross-sectional study. BMC Gastroenterol. 2024;24:296. doi: 10.1186/s12876-024-03373-x. - DOI - PMC - PubMed

Publication types

LinkOut - more resources